Results 101 to 110 of about 40,857 (208)

Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus

ChemMedChem, Volume 21, Issue 20, 28 October 2026.
Respiratory syncytial virus (RSV) remains a major cause of severe respiratory disease, while effective treatments for acute infection are still limited. We screened small‐molecule RSV entry inhibitors and investigated promising hits through resynthesis and antiviral testing.
Christina Karhan, Svenja M. Sake, Melanie Urbanek‐Quaing, Diletta Bergamo, Jessica Rückert, Jiabin Huang, Christina Grethe, Antonia P. Gunesch, Anne Kühnel, Birthe Reinecke, Nicole Fischer, Thomas F. Schulz, Thomas Pietschmann, Anna K. H. Hirsch   +13 more
wiley   +1 more source

Past and Present Vaccinations in Sweden

Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley   +1 more source

PALIVIZUMAB: NEW CAPABILITIES TO PREVENT SEVERE FORMS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN

Педиатрическая фармакология, 2010
Most bronchiolitis cases and viral pneumonias in young children are caused by respiratory syncytial viral (RSV) infection. Children with chronic diseases of lungs, congenital heart defects, pre-mature infants are at high risk of severe type of this ...
T.V. Kulichenko
doaj  

Respiratory syncytial virus: current and emerging treatment options

ClinicoEconomics and Outcomes Research, 2014
Tiffany L Turner,1 Benjamin T Kopp,1 Grace Paul,1 Lindsay C Landgrave,2 Don Hayes Jr,1 Rohan Thompson11Department of Pediatrics, Ohio State University College of Medicine, 2Clinical Pharmacy, Nationwide Children's Hospital, Columbus, OH, USAAbstract:
Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D Jr, Thompson R   +5 more
doaj  

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Biologics: Targets & Therapy, 2008
Asunción Mejías, Octavio RamiloDivision of Pediatric Infectious Diseases, The University of Texas Southwestern Medical Center and Children’s Medical Center, Dallas, Texas, USAAbstract: In respiratory syncytial virus (RSV ...
Asunción Mejías, Octavio Ramilo   +1 more
doaj  

Estimating the National Disease Burden and Economic Burden of Respiratory Syncytial Virus (RSV) in Thailand. [PDF]

Influenza Other Respir Viruses
Boonpattharatthiti K, Techasaensiri C, Phongsamart W, Okada PA, Patikorn C, Praphasiri P, Dhippayom T, Chaiyakunapruk N.   +7 more
europepmc   +1 more source

Respiratory Syncytial Virus (RSV) Vaccine Acceptance Among the Elderly in Al-Qassim Region, Saudi Arabia. [PDF]

Patient Prefer Adherence
Aljohani M, Al-Oraini D.
europepmc   +1 more source

Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination. [PDF]

J Infect Dis
Kachikis A, Frivold C, Pike M, Reed JC, Stolarczuk JE, McVey K, Clark E, Mauer C, McAteer S, Saidac IM, Harteloo A, Carone M, Marshall G, Eckert LO, Greninger AL, Englund JA, Chu HY.   +16 more
europepmc   +1 more source

Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024). [PDF]

PLoS One
de Veras BMG, Michelin L, Croda J, Berra TZ, Pires-Matheus G, Sampietri I, Araujo M, da Silva RM, Guzmán-Holst A.   +8 more
europepmc   +1 more source

Hospital Admissions for Respiratory Syncytial Virus (RSV) Among Elderly: A Retrospective Study From an Italian Southern Region During Years 2018-2023. [PDF]

Influenza Other Respir Viruses
Di Martino G, Di Giovanni P, Vaccaro F, Cascavilla FR, Di Marzio C, Tognaccini L, Trebbi E, Aita T, Romano F, Staniscia T.   +9 more
europepmc   +1 more source